Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OPK |
---|---|---|
09:32 ET | 178015 | 1.235 |
09:34 ET | 417 | 1.24 |
09:36 ET | 66691 | 1.235 |
09:38 ET | 21608 | 1.235 |
09:39 ET | 1500 | 1.23 |
09:41 ET | 968 | 1.24 |
09:43 ET | 10092 | 1.238 |
09:45 ET | 300 | 1.24 |
09:48 ET | 686 | 1.24 |
09:50 ET | 400 | 1.235 |
09:52 ET | 4200 | 1.235 |
09:54 ET | 6200 | 1.235 |
09:56 ET | 350 | 1.235 |
09:57 ET | 8200 | 1.235 |
09:59 ET | 600 | 1.235 |
10:01 ET | 1500 | 1.24 |
10:03 ET | 812 | 1.235 |
10:06 ET | 500 | 1.24 |
10:08 ET | 513 | 1.24 |
10:10 ET | 744 | 1.235 |
10:12 ET | 1155 | 1.235 |
10:14 ET | 7600 | 1.235 |
10:15 ET | 300 | 1.235 |
10:17 ET | 13596 | 1.235 |
10:19 ET | 12192 | 1.235 |
10:21 ET | 500 | 1.235 |
10:24 ET | 7237 | 1.235 |
10:26 ET | 6471 | 1.235 |
10:28 ET | 1803 | 1.24 |
10:30 ET | 776 | 1.24 |
10:32 ET | 1817 | 1.235 |
10:33 ET | 8946 | 1.24 |
10:35 ET | 700 | 1.24 |
10:37 ET | 800 | 1.235 |
10:39 ET | 1001 | 1.235 |
10:42 ET | 4198 | 1.235 |
10:44 ET | 700 | 1.24 |
10:46 ET | 51779 | 1.24 |
10:48 ET | 18070 | 1.235 |
10:50 ET | 300 | 1.235 |
10:51 ET | 2092 | 1.235 |
10:53 ET | 4044 | 1.24 |
10:55 ET | 2370 | 1.235 |
10:57 ET | 2629 | 1.24 |
11:00 ET | 1200 | 1.24 |
11:02 ET | 900 | 1.24 |
11:04 ET | 800 | 1.235 |
11:06 ET | 72589 | 1.235 |
11:08 ET | 6030 | 1.235 |
11:09 ET | 100 | 1.235 |
11:11 ET | 7535 | 1.235 |
11:13 ET | 4241 | 1.235 |
11:15 ET | 4937 | 1.235 |
11:18 ET | 1896 | 1.235 |
11:20 ET | 15100 | 1.235 |
11:22 ET | 16849 | 1.235 |
11:24 ET | 5739 | 1.235 |
11:26 ET | 2200 | 1.24 |
11:27 ET | 1581 | 1.24 |
11:29 ET | 9486 | 1.24 |
11:31 ET | 9210 | 1.24 |
11:33 ET | 1700 | 1.24 |
11:36 ET | 2019 | 1.24 |
11:38 ET | 31000 | 1.24 |
11:40 ET | 2200 | 1.24 |
11:42 ET | 600 | 1.24 |
11:44 ET | 2750 | 1.24 |
11:45 ET | 13720 | 1.235 |
11:47 ET | 37668 | 1.24 |
11:49 ET | 1300 | 1.24 |
11:51 ET | 19720 | 1.235 |
11:54 ET | 2580 | 1.24 |
11:56 ET | 1500 | 1.24 |
11:58 ET | 2539 | 1.24 |
12:00 ET | 1040 | 1.235 |
12:02 ET | 1577 | 1.235 |
12:03 ET | 2757 | 1.235 |
12:05 ET | 800 | 1.235 |
12:07 ET | 20780 | 1.235 |
12:09 ET | 5957 | 1.2303 |
12:12 ET | 14370 | 1.235 |
12:14 ET | 85110 | 1.225 |
12:16 ET | 7348 | 1.225 |
12:18 ET | 6034 | 1.225 |
12:20 ET | 14615 | 1.225 |
12:21 ET | 600 | 1.225 |
12:23 ET | 4395 | 1.23 |
12:25 ET | 1625 | 1.225 |
12:27 ET | 4500 | 1.225 |
12:30 ET | 11186 | 1.225 |
12:32 ET | 1218 | 1.23 |
12:34 ET | 1185 | 1.225 |
12:36 ET | 4016 | 1.225 |
12:38 ET | 1018 | 1.225 |
12:39 ET | 2179 | 1.23 |
12:41 ET | 1619 | 1.225 |
12:43 ET | 1863 | 1.225 |
12:45 ET | 600 | 1.225 |
12:48 ET | 1812 | 1.225 |
12:50 ET | 876 | 1.225 |
12:52 ET | 1233 | 1.23 |
12:54 ET | 16594 | 1.225 |
12:56 ET | 1200 | 1.225 |
12:57 ET | 3111 | 1.225 |
12:59 ET | 3859 | 1.225 |
01:01 ET | 6400 | 1.225 |
01:03 ET | 3224 | 1.225 |
01:06 ET | 1000 | 1.225 |
01:08 ET | 700 | 1.23 |
01:10 ET | 5873 | 1.225 |
01:12 ET | 15053 | 1.225 |
01:14 ET | 1353 | 1.23 |
01:15 ET | 800 | 1.225 |
01:17 ET | 1197 | 1.225 |
01:19 ET | 1368 | 1.225 |
01:21 ET | 3509 | 1.225 |
01:24 ET | 1290 | 1.225 |
01:26 ET | 800 | 1.23 |
01:28 ET | 1510 | 1.23 |
01:30 ET | 5403 | 1.225 |
01:32 ET | 2714 | 1.225 |
01:33 ET | 1815 | 1.225 |
01:35 ET | 1646 | 1.225 |
01:37 ET | 4434 | 1.225 |
01:39 ET | 1887 | 1.225 |
01:42 ET | 2046 | 1.225 |
01:44 ET | 1967 | 1.23 |
01:46 ET | 1730 | 1.225 |
01:48 ET | 5392 | 1.23 |
01:50 ET | 16404 | 1.225 |
01:51 ET | 1540 | 1.225 |
01:53 ET | 1665 | 1.225 |
01:55 ET | 2752 | 1.225 |
01:57 ET | 5838 | 1.22 |
02:00 ET | 6263 | 1.225 |
02:02 ET | 8974 | 1.225 |
02:04 ET | 12269 | 1.23 |
02:06 ET | 13520 | 1.23 |
02:08 ET | 20430 | 1.225 |
02:09 ET | 4262 | 1.23 |
02:11 ET | 9214 | 1.225 |
02:13 ET | 13840 | 1.225 |
02:15 ET | 8030 | 1.224 |
02:18 ET | 13643 | 1.224 |
02:20 ET | 8160 | 1.23 |
02:22 ET | 19069 | 1.2211 |
02:24 ET | 4133 | 1.23 |
02:26 ET | 6302 | 1.23 |
02:27 ET | 8009 | 1.225 |
02:29 ET | 16818 | 1.23 |
02:31 ET | 26257 | 1.225 |
02:33 ET | 1374 | 1.225 |
02:36 ET | 1300 | 1.23 |
02:38 ET | 9435 | 1.23 |
02:40 ET | 6947 | 1.23 |
02:42 ET | 39054 | 1.23 |
02:44 ET | 25038 | 1.225 |
02:45 ET | 1900 | 1.225 |
02:47 ET | 135922 | 1.225 |
02:49 ET | 45418 | 1.225 |
02:51 ET | 13300 | 1.225 |
02:54 ET | 74493 | 1.23 |
02:56 ET | 8600 | 1.23 |
02:58 ET | 4929 | 1.23 |
03:00 ET | 2851 | 1.235 |
03:02 ET | 434 | 1.235 |
03:03 ET | 2510 | 1.23 |
03:05 ET | 500 | 1.235 |
03:07 ET | 900 | 1.235 |
03:09 ET | 1979 | 1.24 |
03:12 ET | 1178 | 1.235 |
03:14 ET | 14056 | 1.235 |
03:16 ET | 1092 | 1.23 |
03:18 ET | 5500 | 1.235 |
03:20 ET | 1276 | 1.235 |
03:21 ET | 5085 | 1.235 |
03:23 ET | 1394 | 1.235 |
03:25 ET | 89554 | 1.225 |
03:27 ET | 6112 | 1.225 |
03:30 ET | 1499 | 1.22 |
03:32 ET | 4451 | 1.22 |
03:34 ET | 7225 | 1.225 |
03:36 ET | 24395 | 1.23 |
03:38 ET | 17973 | 1.23 |
03:39 ET | 19247 | 1.23 |
03:41 ET | 70220 | 1.24 |
03:43 ET | 24869 | 1.23 |
03:45 ET | 22341 | 1.23 |
03:48 ET | 8066 | 1.235 |
03:50 ET | 34261 | 1.235 |
03:52 ET | 14850 | 1.235 |
03:54 ET | 20401 | 1.235 |
03:56 ET | 41325 | 1.23 |
03:57 ET | 23041 | 1.23 |
03:59 ET | 416350 | 1.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
OPKO Health Inc | 857.3M | -4.9x | --- |
Accolade Inc | 709.8M | -5.5x | --- |
Pennant Group Inc | 604.5M | 45.8x | -5.49% |
InnovAge Holding Corp | 543.6M | -17.0x | --- |
Enhabit Inc | 506.8M | -6.3x | --- |
Community Healthcare Trust Inc | 697.3M | 137.9x | +1.34% |
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $857.3M |
---|---|
Revenue (TTM) | $863.5M |
Shares Outstanding | 697.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.80 |
EPS | $-0.25 |
Book Value | $1.80 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -18.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.